semaglutide 0.25 mg pen Administration calorie diet program to help you lose weight Wegovy 0.25 mg/0.5 mL pre-filled

GLP-1 receptors exist on immune cells, not just in the pancreas or the gut

Hydration and Monitoring Maintaining adequate hydration is essential when using both medications: Wegovy can cause nausea, vomiting, or diarrhoea, potentially leading to dehydration Dehydration can increase the risk of NSAID-related kidney problems Ensure regular fluid intake, particularly during Wegovy dose escalation phases For long-term NSAID therapy, the Specialist Pharmacy Service recommends baseline and periodic monitoring of renal function, blood pressure, and full blood count

The most common injection sites are the stomach (abdomen), the front of your thighs, or your upper arm

FDA Newsroom